These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

167 related items for PubMed ID: 5670163

  • 1. [Importance of the clofibrat in the treatment of lipid metabolism disorders].
    Laubinger G.
    Med Klin; 1968 Jan 26; 63(4):139-42. PubMed ID: 5670163
    [No Abstract] [Full Text] [Related]

  • 2. [Action mechanism and clinical success of Regelan (Clofibrate)].
    Fitzgerald JD.
    Wien Klin Wochenschr; 1967 Sep 29; 79(39):716-20. PubMed ID: 5595437
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Clofibrate and androsterone effect on serum lipids.
    Orgain ES, Bogdonoff MD, Cain C.
    Arch Intern Med; 1967 Jan 29; 119(1):80-5. PubMed ID: 6015838
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Hyperlipidemias: occurrence, significance, therapy].
    Knüchel F.
    Med Welt; 1967 Aug 12; 32():1848-60. PubMed ID: 5589916
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Atromid-S for the reduction of plasma lipids.
    Med Lett Drugs Ther; 1967 Jun 16; 9(12):45-7. PubMed ID: 6037633
    [No Abstract] [Full Text] [Related]

  • 9. [Clinical contribution to the study of the eulipemic effect of 2 ethyl esters of p-chlorophenoxyisobutyric acid].
    De Michelis S, Paparella P, Seu V.
    Clin Ter; 1969 Jul 15; 50(1):11-26. PubMed ID: 4917326
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Drug therapy of dyslipidemias].
    Fonda M, Cattin L, Guarnieri G.
    Recenti Prog Med; 2000 Jul 15; 91(7-8):375-8. PubMed ID: 10932924
    [No Abstract] [Full Text] [Related]

  • 14. The primary preventiono of ischemic heart disease by means of Atromid-S (clofibrate).
    Oliver MF.
    Bull N Y Acad Med; 1968 Aug 15; 44(8):1021-7. PubMed ID: 4875747
    [No Abstract] [Full Text] [Related]

  • 15. Long-term therapy of adult cases of primary hypertriglyceridaemia with clofibrate (ethyl-p-chlorophenoxyisobutyrate).
    Braunsteiner H, Herbst M, Sandhofer F, Sailer S.
    Ger Med Mon; 1968 Feb 15; 13(2):65-72. PubMed ID: 5653144
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Prevention of cardiovascular diseases: Value of CSE inhibitors in the management of lipid metabolism disorders].
    Z Kardiol; 1998 Apr 15; 87(4 Suppl Stellenwer):1-4. PubMed ID: 9618894
    [No Abstract] [Full Text] [Related]

  • 19. Mode of action of chlorophenoxyisobutyric acid on cholesterol metabolism in man.
    Horlick L, Kudchodkar BJ, Sodhi HS.
    Circulation; 1971 Feb 15; 43(2):299-309. PubMed ID: 5540713
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.